Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Acotec Scientific Holdings Limited ( (HK:6669) ) has shared an announcement.
Acotec Scientific Holdings Limited has announced the approval of its Sirolimus-Coated Coronary Balloon Dilatation Catheter, AcoArt Canna®, by the PRC National Medical Products Administration. This device is designed for treating de novo coronary artery bifurcation lesions and has shown efficacy and safety in clinical trials. The company plans to initiate marketing activities in the Chinese market, although there is no guarantee of successful commercialization.
More about Acotec Scientific Holdings Limited
Acotec Scientific Holdings Limited is a company incorporated in the Cayman Islands, operating in the medical device industry. The company focuses on developing innovative medical products, including devices for coronary artery treatments, and is actively involved in the Chinese market.
YTD Price Performance: 103.02%
Average Trading Volume: 394,206
Technical Sentiment Signal: Buy
Current Market Cap: HK$3.8B
Find detailed analytics on 6669 stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money